Andrew Hull In Med Pharmaceuticals Inc. (INM) insider trading activity

INM Quotes by TradingView

Andrew Hull is Director of InMed Pharmaceuticals Inc.. Currently has a direct ownership of 38,258 shares of INM, which is worth approximately $9,947. The most recent transaction as insider was on Feb 21, 2024, when has been sold 37,500 shares (Common Stock) at a price of $0.39 per share, resulting in proceeds of $14,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.3K
0% 3M change
n/a 12M change
Total Value Held $9,947

ANDREW HULL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2024
BUY
Open market or private purchase
$14,625 $0.39 p/Share
37,500 Added 49.5%
38,258 Common Stock
AH

Andrew Hull

Director
Vancouver, A1

Track Institutional and Insider Activities on INM

Follow InMed Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INM shares.

Notify only if

Insider Trading

Get notified when an In Med Pharmaceuticals Inc. insider buys or sells INM shares.

Notify only if

News

Receive news related to InMed Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INM